Historical review from 2026-10-03. Current price and availability are unconfirmed; check the original marketplace.
Scantrader generates $13.7K/mo with exceptional 85% margins and trades at a 2.5x annual profit multiple—both strong indicators. However, the business is only 4 months old, raising material questions about revenue sustainability, customer acquisition durability, and whether the current run rate will persist. The limited business description and early stage require a buyer to independently verify that this is repeatable revenue with defensible unit economics rather than a brief spike.
The core software stack for a trading-analysis tool (data ingestion, AI signal generation, charting, alert logic) can be assembled in 8 weeks using modern AI SDKs, API-first market data providers, and no-code trading dashboards—estimated cash cost $8K–$18K. However, the deal's value is fundamentally the verified $13.7K/mo revenue and 85% margins. The decisive factor is that the business is only 4 months old with no demonstrated retention, customer concentration, or acquisition-channel durability. Buying verifies immediate cash flow but carries high risk that the revenue declines once early adopters or promotional conditions change. Building carries the execution risk of product-market fit but preserves optionality and avoids overpaying for unproven traction. Given the age and lack of retention/churn visibility, build is the lower-risk path unless the buyer can independently confirm a diverse, sticky customer base and repeatable acquisition economics.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
Highly profitable AI-powered fintech software for trading analysis.
Opens the original listing on TrustMRR
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.